PaxVax, Inc. Announces New Commercial Senior Leadership Appointments
3/3/2014 7:29:30 AM
PaxVax Inc., a specialty vaccine company focused on travelers and biodefense markets with a social mission to ensure global access to its vaccines, today announced the expansion of its commercial leadership team, including appointments of: Linda Rubinstein as Chief Financial Officer; Piers Whitehead as Chief Corporate Development Officer; and Thomas Yonker as Vice President of Project Management.
Help employers find you! Check out all the jobs and post your resume.
comments powered by